Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Immunohematology·2021

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Bone marrow transplantation·2017

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

BMC cancer·2017

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Oncogenesis·2017

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017

A new reporter strategy reveals a subset of nonmigratory hematopoietic stem cells located in a dynamic bone marrow niche.

Blood·2026

A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years.

Blood·2026

Cases of High-Titer Inhibitor Formation After AAV Gene Therapy for Hemophilia A.

Blood·2026

Genomic and clinical landscape of RAS mutations in acute myeloid leukemia.

Blood·2026

Molecular Consequences and Targeting of PPM1D Overexpression in Myeloproliferative Neoplasms.

Blood·2026

Ambient oxygen disrupts amino acid homeostasis and impairs human hematopoietic stem and progenitor cell engraftment.

Blood·2026

Pembrolizumab-Associated Adrenal Insufficiency Presenting as Adrenal Crisis: A Case Report.

Cureus·2026

Engineering immune cell engagers: From molecular constructs to biomaterial platforms.

Materials today. Bio·2026

Disseminated Tuberculosis With Ocular Involvement After 12 Years of Anti-TNF-α Therapy.

Case reports in ophthalmological medicine·2026

Effects of intensive insulin therapy combined with non-insulin antihyperglycemic agents on glycemic control, variability, and metabolic outcomes in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Frontiers in endocrinology·2026

Genetically Defined Acute Myeloid Leukemia Induced Pluripotent Stem Cell Clones Reveal Selective Impairment of Hematopoietic Development.

Stem cells and development·2026

Off-Label Use of Monoclonal Antibodies in Developing Countries.

American journal of therapeutics·2026

Related Experiment Videos

Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor

Related Concept Videos

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

A new reporter strategy reveals a subset of nonmigratory hematopoietic stem cells located in a dynamic bone marrow niche.

A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years.

Cases of High-Titer Inhibitor Formation After AAV Gene Therapy for Hemophilia A.

Genomic and clinical landscape of RAS mutations in acute myeloid leukemia.

Molecular Consequences and Targeting of PPM1D Overexpression in Myeloproliferative Neoplasms.

Ambient oxygen disrupts amino acid homeostasis and impairs human hematopoietic stem and progenitor cell engraftment.

Pembrolizumab-Associated Adrenal Insufficiency Presenting as Adrenal Crisis: A Case Report.

Engineering immune cell engagers: From molecular constructs to biomaterial platforms.

Disseminated Tuberculosis With Ocular Involvement After 12 Years of Anti-TNF-α Therapy.

Effects of intensive insulin therapy combined with non-insulin antihyperglycemic agents on glycemic control, variability, and metabolic outcomes in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Genetically Defined Acute Myeloid Leukemia Induced Pluripotent Stem Cell Clones Reveal Selective Impairment of Hematopoietic Development.

Off-Label Use of Monoclonal Antibodies in Developing Countries.

Related Experiment Videos

Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor

Related Concept Videos

Related Articles